Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, United Kingdom; Leeds Institute of Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
Farncombe Family Digestive Health Research Institute, Gastroenterology Division, McMaster University, Health Sciences Center, Hamilton, Ontario, Canada.
Gastroenterology. 2014 Apr;146(4):932-40; quiz e14-5. doi: 10.1053/j.gastro.2014.01.014. Epub 2014 Jan 11.
BACKGROUND & AIMS: Although the Rome III criteria for functional dyspepsia were defined 7 years ago, they have yet to be validated in a rigorous study. We addressed this issue in a secondary-care population. METHODS: We analyzed complete symptom, upper gastrointestinal (GI) endoscopy, and histology data from 1452 consecutive adult patients with GI symptoms at 2 hospitals in Hamilton, Ontario, Canada. Assessors were blinded to symptom status. Individuals with normal upper GI endoscopy and histopathology findings from analyses of biopsy specimens were classified as having no organic GI disease. The reference standard used to define the presence of true functional dyspepsia was epigastric pain, early satiety or postprandial fullness, and no organic GI disease. Sensitivity, specificity, and positive and negative likelihood ratios (LRs), with 95% confidence intervals (CIs), were calculated. RESULTS: Of the 1452 patients, 722 (49.7%) met the Rome III criteria for functional dyspepsia. Endoscopy showed organic GI disease in 170 patients (23.5%) who met the Rome III criteria. The Rome III criteria identified patients with functional dyspepsia with 60.7% sensitivity, 68.7% specificity, a positive LR of 1.94 (95% CI, 1.69-2.22), and a negative LR of 0.57 (95% CI, 0.52-0.63). In contrast, the Rome II criteria identified patients with functional dyspepsia with 71.4% sensitivity, 55.6% specificity, a positive LR of 1.61 (95% CI, 1.45-1.78), and a negative LR of 0.51 (95% CI, 0.45-0.58). The area under a receiver operating characteristics curves did not differ significantly for any of the diagnostic criteria for functional dyspepsia. CONCLUSIONS: In a validation study of 1452 patients with GI symptoms, the Rome III criteria performed only modestly in identifying those with functional dyspepsia, and were not significantly superior to previous definitions.
背景与目的:尽管功能性消化不良的罗马 III 标准于 7 年前被定义,但它们尚未在严格的研究中得到验证。我们在二级保健人群中解决了这个问题。
方法:我们分析了加拿大安大略省汉密尔顿的 2 家医院的 1452 例连续成年胃肠道症状患者的完整症状、上胃肠道(GI)内镜和组织学数据。评估人员对症状状况进行了盲法评估。从活检标本分析中发现 GI 内镜和组织病理学检查结果正常的个体被归类为没有器质性 GI 疾病。用于定义真正功能性消化不良存在的参考标准是上腹痛、早饱或餐后饱胀以及没有器质性 GI 疾病。计算了敏感性、特异性、阳性和阴性似然比(LR)及其 95%置信区间(CI)。
结果:在 1452 例患者中,有 722 例(49.7%)符合功能性消化不良的罗马 III 标准。符合罗马 III 标准的 170 例(23.5%)患者内镜检查显示存在器质性 GI 疾病。罗马 III 标准诊断功能性消化不良患者的敏感性为 60.7%,特异性为 68.7%,阳性 LR 为 1.94(95%CI,1.69-2.22),阴性 LR 为 0.57(95%CI,0.52-0.63)。相比之下,罗马 II 标准诊断功能性消化不良患者的敏感性为 71.4%,特异性为 55.6%,阳性 LR 为 1.61(95%CI,1.45-1.78),阴性 LR 为 0.51(95%CI,0.45-0.58)。任何功能性消化不良诊断标准的受试者工作特征曲线下面积均无显著差异。
结论:在对 1452 例胃肠道症状患者的验证研究中,罗马 III 标准在识别功能性消化不良患者方面表现仅为中等,并且与之前的定义没有显著差异。
Gastroenterology. 2013-8-28
J Pediatr Gastroenterol Nutr. 2014-6
J Clin Gastroenterol. 2009-2
Neurogastroenterol Motil. 2015-8
World J Gastroenterol. 2020-8-14
Middle East J Dig Dis. 2025-1
J Clin Transl Hepatol. 2021-12-28
World J Gastroenterol. 2020-8-14